Tag Archives: FDA Advisory Committee

July, 2016

• 20 July

  FDA Panel Recommends Approval of Valeant’s Psoriasis Drug

  

  LAVAL, Quebec, July 19, 2016 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) has voted by a margin of 18 to 0 for the approval of brodalumab injection, 210 …

  Share

  • Facebook
  • Twitter
  • LinkedIn

April, 2016

• 8 April

  Clovis Oncology Announces NSCLC Drug Briefing Documents Posted by FDA

  

  BOULDER, Colo.–(BUSINESS WIRE)–Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the U.S. Food and Drug Administration (FDA) posted briefing materials in advance of the Oncologic Drugs Advisory Committee (ODAC) meeting to discuss accelerated approval of the New Drug Application (NDA) for rociletinib, an investigational therapy for the treatment of patients …

  Share

  • Facebook
  • Twitter
  • LinkedIn